<SEC-DOCUMENT>0001167379-21-000029.txt : 20211108
<SEC-HEADER>0001167379-21-000029.hdr.sgml : 20211108
<ACCEPTANCE-DATETIME>20211108084117
ACCESSION NUMBER:		0001167379-21-000029
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20211108
FILED AS OF DATE:		20211108
DATE AS OF CHANGE:		20211108

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALCON INC
		CENTRAL INDEX KEY:			0001167379
		STANDARD INDUSTRIAL CLASSIFICATION:	OPHTHALMIC GOODS [3851]
		IRS NUMBER:				980205094
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31269
		FILM NUMBER:		211386656

	BUSINESS ADDRESS:	
		STREET 1:		6201 SOUTH FREEWAY
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76134
		BUSINESS PHONE:		817 293 0450

	MAIL ADDRESS:	
		STREET 1:		CHEMIN DE BLANDONNET 8
		STREET 2:		1214 VERNIER
		CITY:			GENEVA
		STATE:			V8
		ZIP:			0000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6-kxnovember2021.htm
<DESCRIPTION>6-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i515f6999b27f4b85b3ac45bf52767a0a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Washington, D.C. 20549</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_________________</font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:22pt;font-weight:700;line-height:120%">FORM 6-K </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_________________</font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:13pt;font-weight:700;line-height:120%">REPORT OF FOREIGN PRIVATE ISSUER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:13pt;font-weight:700;line-height:120%">PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:13pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:700;line-height:120%">November 8, 2021</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Commission File Number&#58; 001-31269 </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_________________</font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:22pt;font-weight:700;line-height:120%">ALCON INC. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant Name)</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rue Louis-d'Affry 6</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <br></font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1701, Fribourg, Switzerland </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive office)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_________________</font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20&#8209;F or Form 40-F&#58;  Form 20-F </font><font style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9746;</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;Form 40-F </font><font style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)&#58; </font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">         </font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)&#58; </font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">         </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i515f6999b27f4b85b3ac45bf52767a0a_7"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:700;line-height:130%">EXHIBIT INDEX</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:10.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit<br>Number</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="alconithacapressrelease.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Press release issued by Alc</a></font><font style="background-color:#ffffff;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="alconithacapressrelease.htm" style="-sec-extract:exhibit;background-color:#ffffff;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">on Inc. dat</a><a href="alconithacapressrelease.htm" style="-sec-extract:exhibit;background-color:#ffffff;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">e</a></font><font style="color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="alconithacapressrelease.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">d </a><a href="alconithacapressrelease.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">November 8</a><a href="alconithacapressrelease.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">, 2021</a><a href="alconithacapressrelease.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> tit</a><a href="alconithacapressrelease.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">l</a><a href="alconithacapressrelease.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ed &#8220;</a><a href="alconithacapressrelease.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Alcon to Acquire I</a><a href="alconithacapressrelease.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">vanti</a><a href="alconithacapressrelease.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">s, Inc. and its Hydrus Microstent for Surgical Glaucoma</a><a href="alconithacapressrelease.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">, </a><a href="alconithacapressrelease.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Strengthening Global Ophthalmology Portfolio&#34;</a></font></div></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><div id="i515f6999b27f4b85b3ac45bf52767a0a_10"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:4.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.158%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.164%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ALCON INC.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 8, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Timothy C. Stonesifer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Timothy C. Stonesifer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; Authorized Representative</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 8, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Royce Bedward</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Royce Bedward</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; Authorized Representative</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-indent:288pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>alconithacapressrelease.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i77e23344555c4f4499c486de48b73f3c_68"></div><div style="min-height:0pt;width:100%"><div style="margin-bottom:6pt"><font><br></font></div></div><div style="text-align:center"><img alt="logopressrelease2a01a.jpg" src="logopressrelease2a01a.jpg" style="height:294px;margin-bottom:5pt;vertical-align:text-bottom;width:816px"></div><div style="text-align:center"><font><br></font></div><div style="padding-right:-15.4pt"><font style="color:#003595;font-family:'Open Sans',sans-serif;font-size:17pt;font-weight:700;line-height:115%">Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio</font></div><div style="padding-right:-15.4pt"><font><br></font></div><div style="margin-bottom:5pt;padding-left:13.5pt;padding-right:-15.4pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:8.99pt">Expands Alcon&#8217;s leading surgical portfolio and leverages the company&#8217;s commercial execution expertise  </font></div><div style="margin-bottom:5pt;padding-left:13.5pt;padding-right:-15.4pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:8.99pt">Strong safety and efficacy profile evidenced by five-year study on Hydrus Microstent, a minimally invasive glaucoma surgery (MIGS) device </font></div><div style="margin-bottom:5pt;padding-left:13.5pt;padding-right:-15.4pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:8.99pt">Indicated to lower intraocular pressure for open-angle glaucoma patients in connection with cataract surgery*, Hydrus Microstent is part of a large surgical glaucoma market with a growing patient population </font></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:13.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Open Sans',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Ad hoc announcement pursuant to Art. 53 LR</font><font style="background-color:#ffffff;color:#000000;font-family:'Open Sans',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</font></div><div><font><br></font></div><div style="padding-right:-15.4pt"><font style="color:#00aeef;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:700;line-height:115%">GENEVA, November 8 </font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">&#8211; Alcon (SIX&#47;NYSE&#58; ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced its intention to acquire Ivantis</font><font style="background-color:#ffffff;color:#000000;font-family:'Open Sans',sans-serif;font-size:7.15pt;font-weight:400;line-height:115%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">, developer and manufacturer of the novel Hydrus</font><font style="background-color:#ffffff;color:#000000;font-family:'Open Sans',sans-serif;font-size:7.15pt;font-weight:400;line-height:115%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%"> Microstent, a minimally-invasive glaucoma surgery (MIGS) device designed to lower intraocular pressure for open-angle glaucoma patients in connection with cataract surgery*. The intended acquisition affirms Alcon&#8217;s commitment to the surgical glaucoma space, further strengthening its industry-leading portfolio across cataract, refractive, retina and glaucoma. </font></div><div><font><br></font></div><div style="padding-right:-15.4pt"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">The five-year HORIZON clinical study of Hydrus Microstent is the longest, continuous follow-up of a MIGS device. It demonstrated that 65% of Hydrus Microstent patients remained medication-free at five years post-implant. The results also showed over 60% reduction in risk of invasive secondary glaucoma surgeries compared to cataract surgery alone &#8211; and its safety profile was sustained through the five-year follow up.</font><font style="background-color:#ffffff;color:#000000;font-family:'Open Sans',sans-serif;font-size:6.82pt;font-weight:400;line-height:115%;position:relative;top:-3.67pt;vertical-align:baseline">1</font><font style="background-color:#ffffff;color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%"> Among MIGS rated in the 2020 American Academy of Ophthalmology Primary Open-Angle Glaucoma Preferred Practice Pattern (PPP), the Hydrus Microstent received the highest grade for quality body of evidence and a strong recommendation.</font><font style="background-color:#ffffff;color:#000000;font-family:'Open Sans',sans-serif;font-size:6.82pt;font-weight:400;line-height:115%;position:relative;top:-3.67pt;vertical-align:baseline">2</font></div><div><font><br></font></div><div style="padding-right:-15.4pt"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">&#8220;Glaucoma is the second-largest cause of blindness after cataracts, impacting more than 75 million people globally, with significant unmet patient need. This transaction will allow us to add a uniquely effective product into our glaucoma portfolio around the world,&#34; said David Endicott, CEO of Alcon. &#34;Our global commercial footprint and development capabilities make us well positioned to build on the success of Ivantis and help even more patients see brilliantly with Hydrus Microstent.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:132%">1</font></div><div style="text-align:justify"><font><br></font></div></div></div><div id="i77e23344555c4f4499c486de48b73f3c_1"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:112%">&#8220;With more than 85,000 Hydrus devices implanted, now is the time to expand access globally, and Alcon is the right partner as the global leader in eye care,&#8221; said Dave Van Meter, President and CEO of Ivantis. &#8220;We started this with a mission to bring unprecedented scientific rigor to the MIGS space, and we are gratified and humbled by the rapid adoption of Hydrus since our launch in late 2018. Thanks to the relentless, unwavering commitment of Ivantis employees and our investors, we now have the opportunity to bring the clinically proven Hydrus technology to more glaucoma patients worldwide.&#8221;</font></div><div style="padding-right:-15.4pt"><font><br></font></div><div style="padding-right:-15.4pt"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">Hydrus Microstent was approved by the FDA in&#160;August 2018&#160;for use in conjunction with cataract surgery in the United States. In the UK, Canada, Australia, Singapore, and Germany, the MIGS device is indicated for primary open-angle glaucoma in conjunction with cataract surgery or as a stand-alone procedure.</font></div><div style="padding-right:-15.4pt"><font><br></font></div><div style="padding-right:-15.4pt"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">Alcon will pay $475 million in upfront consideration to acquire Ivantis, Inc.&#160;Alcon may be required to make additional contingent payments upon the achievement of certain regulatory and commercial milestones.&#160;The transaction is anticipated to close in the first quarter of 2022 subject to customary closing conditions, including regulatory approval.</font></div><div style="padding-right:-7.7pt;text-align:center"><font><br></font></div><div style="padding-right:-15.4pt"><font style="color:#003595;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:700;line-height:115%;text-decoration:underline">About Hydrus Microstent </font></div><div style="padding-right:-15.4pt"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">Roughly the size of an eyelash, the Hydrus Microstent is a next-generation MIGS device designed to reduce eye pressure by reestablishing flow through Schlemm's canal, the eye's natural outflow pathway. When placed in the canal during minimally invasive microsurgery, the device restores the flow of fluid in the eye, using a Tri-Modal</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:6.82pt;font-weight:400;line-height:115%;position:relative;top:-3.67pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%"> mechanism of action&#58;</font></div><div style="padding-right:-15.4pt"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">the Hydrus Microstent dilates and scaffolds Schlemm's canal to augment outflow of aqueous humor from the anterior chamber. It maintains an opening through the trabecular meshwork from the anterior chamber into Schlemm's canal. Its length spans approximately 90 degrees of the canal to provide consistent access to multiple fluid collector channels in the eye. Approved by the FDA in&#160;August 2018&#160;for use in conjunction with cataract surgery, the Hydrus Microstent is one of the most rigorously researched and thoroughly studied MIGS devices.</font></div><div style="padding-right:-15.4pt"><font><br></font></div><div style="padding-right:-15.4pt"><font style="color:#003595;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:700;line-height:115%;text-decoration:underline">About Ivantis</font></div><div style="padding-right:-15.4pt"><font style="color:#090304;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">Ivantis Inc. is a privately-held company established in 2007 to design, develop and commercialize new technologies to treat eye disease. Investors include New Enterprise Associates, Delphi Ventures, Foresite Capital, RA Capital Management, Ascension Ventures, EDBI, GBS Ventures, MemorialCare Innovation Fund, Merieux Development and Vertex Healthcare. The company is headquartered in&#160;Irvine,&#160;California. Ivantis, Hydrus and Tri-Modal are registered trademarks of Ivantis Inc.&#160;All rights reserved 2020.</font></div><div style="padding-right:-15.4pt"><font><br></font></div><div style="padding-right:-15.4pt;text-align:justify"><font style="color:#003595;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:700;line-height:115%;text-decoration:underline">About Alcon</font></div><div style="padding-right:-15.4pt"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people&#8217;s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 23,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care. Learn more at&#160;</font><font style="color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%;text-decoration:underline">www.alcon.com</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">.</font></div><div style="padding-right:-15.4pt"><font><br></font></div><div style="padding-right:-15.4pt"><font style="color:#003595;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:700;line-height:115%;text-decoration:underline">References</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#090304;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">1.</font><font style="background-color:#ffffff;color:#090304;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%;padding-left:9.21pt">Ahmed, I.K. (2021, Mar. 4-7). 5 Year Follow Up from the HORIZON Trial. American Glaucoma Society Virtual Annual Meeting.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">2.</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%;padding-left:9.21pt">Primary Open-Angle Glaucoma Preferred Practice Pattern</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:6.82pt;font-weight:400;line-height:115%;position:relative;top:-3.67pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">. Gedde, Steven J. et al. Ophthalmology 2020&#59;128(1)&#58; 71-150.</font></div><div><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-style:italic;font-weight:400;line-height:115%">*</font><font style="background-color:#ffffff;color:#242424;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-style:italic;font-weight:400;line-height:115%">Currently approved for standalone use and commercialized in </font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-style:italic;font-weight:400;line-height:115%">the UK, Canada, Australia, Singapore, and Germany.</font></div><div style="padding-right:-15.4pt"><font><br></font></div><div style="padding-right:-15.4pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:132%">2</font></div><div style="padding-right:1.65pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:6pt"><font><br></font></div></div><div style="padding-right:-15.4pt"><font style="color:#003595;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:700;line-height:115%;text-decoration:underline">Forward-looking Statements</font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">This press release contains, and our officers and representatives may from time to time make, certain &#8220;forward-looking statements&#8221; within the meaning of the safe harbor provisions of the US Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as&#58; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;commitment,&#8221; &#8220;look forward,&#8221; &#8220;maintain,&#8221; &#8220;plan,&#8221; &#8220;goal,&#8221; &#8220;seek,&#8221; &#8220;target,&#8221; &#8220;assume,&#8221; &#8220;believe,&#8221; &#8220;project,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;strategy,&#8221; &#8220;future,&#8221; &#8220;likely,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;will&#8221; and similar references to future periods. Examples of forward-looking statements include, among others, statements Alcon makes regarding its plans and decisions relating to the acquisition of Ivantis Inc. and the manufacture, distribution, marketing and&#47;or sale of the Hydrus</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:6.82pt;font-weight:400;line-height:115%;position:relative;top:-3.67pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%"> Microstent&#59; the ability of Alcon to execute on these plans&#59; market growth assumptions&#59; and generally, its expectations concerning its future performance. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:112%">Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on Alcon&#8217;s current beliefs, expectations and assumptions regarding the future of its business, future plans and strategies, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties and risks that are difficult to predict such as&#58; the effect of the COVID-19 pandemic as well as other viral or disease outbreaks and the availability and the public&#8217;s acceptance of vaccines&#59; the commercial success of its products and its ability to maintain and strengthen its position in its markets&#59; the success of its research and development efforts, including its ability to innovate to compete effectively&#59; its success in completing and integrating strategic acquisitions&#59; the possibility that various closing conditions for the transaction may not be satisfied or waived, including that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of the transaction&#59; transaction costs&#59; pricing pressure from changes in third party payor coverage and reimbursement methodologies&#59; global and regional economic, financial, legal, tax, political, and social change&#59; data breaches or other disruptions of its information technology systems&#59; ongoing industry consolidation&#59; its ability to properly educate and train healthcare providers on its products&#59; changes in inventory levels or buying patterns of its customers&#59; the impact of a disruption in its global supply chain or important facilities&#59; ability to service its debt obligations&#59; its ability to comply with the US Foreign Corrupt Practices Act of 1977 and other applicable anti-corruption laws, particularly given that it has entered into a three-year Deferred Prosecution Agreement with the US Department of Justice&#59; uncertainty and impact relating to the potential phasing out of LIBOR and transition to alternative reference rates&#59; the need for additional financing through the issuance of debt or equity&#59; its reliance on outsourcing key business functions&#59; its ability to protect its intellectual property&#59; the impact of unauthorized importation of its products from countries with lower prices to countries with higher prices&#59; uncertainties regarding the success of Alcon's separation and Spin-off from Novartis and the subsequent transformation program, including the expected separation and transformation costs, as well as any potential savings, incurred or realized by Alcon&#59; the effects of litigation, including product liability lawsuits and government investigations&#59; its ability to comply with all laws to which it may be subject&#59; effect of product recalls or voluntary market withdrawals&#59; the implementation of its enterprise resource planning system&#59; its ability to attract and retain qualified personnel&#59; the accuracy of its accounting estimates and assumptions, including pension plan obligations and the carrying value of intangible assets&#59; the ability to obtain regulatory clearance and approval of its products as well as compliance with any post-approval obligations, including quality control of its manufacturing&#59; legislative and regulatory reform&#59; the ability of Alcon Pharmaceuticals Ltd. to comply with its investment tax incentive agreement with the Swiss State Secretariat for Economic Affairs in Switzerland and the Canton of Fribourg, Switzerland&#59; its ability to manage environmental, social and governance matters to the satisfaction of its many stakeholders, some of which may have competing interests&#59; its ability to operate as a stand-alone company&#59; whether the transitional services Novartis has agreed to provide Alcon are sufficient&#59; the impact of the spin-off from Novartis on Alcon's shareholder base&#59; the impact of being listed on two stock exchanges&#59; the ability to declare and pay dividends&#59; the different rights afforded to its shareholders as a Swiss corporation compared to a US corporation&#59; and the effect of maintaining or losing its foreign private issuer status under US securities laws. Additional factors are discussed in Alcon&#8217;s filings with the United States Securities and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:132%">3</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:6pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:112%">Exchange Commission, including its Form 20-F. Should one or more of these uncertainties or risks materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated. Therefore, you should not rely on any of these forward-looking statements.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:112%">Forward-looking statements in this press release speak only as of the date of its filing, and Alcon assumes no obligation to update forward-looking statements as a result of new information, future events or otherwise.</font></div><div style="padding-right:-15.4pt"><font><br></font></div><div style="padding-right:-15.4pt"><font style="color:#1f497d;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:700;line-height:115%">Connect with us on</font></div><div style="padding-right:-15.4pt"><font><br></font></div><div style="padding-right:13.5pt"><img alt="alcon2q19pressrelease_imagb.gif" src="alcon2q19pressrelease_imagb.gif" style="height:37px;margin-bottom:5pt;vertical-align:text-bottom;width:37px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">  </font><img alt="alcon2q19pressrelease_imagc.gif" src="alcon2q19pressrelease_imagc.gif" style="height:38px;margin-bottom:5pt;vertical-align:text-bottom;width:41px"></div><div style="padding-right:13.5pt"><font style="color:#1f487c;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:700;line-height:144%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">  </font></div><div style="padding-right:13.5pt"><font><br></font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.867%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div id="i77e23344555c4f4499c486de48b73f3c_4"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.011%"><div style="padding-right:-15.4pt;text-align:justify"><font style="color:#00aeef;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:700;line-height:115%;text-decoration:underline">Investor Relations </font></div><div style="padding-right:-15.4pt;text-align:justify"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">Karen King</font></div><div style="padding-right:-15.4pt;text-align:justify"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">Allen Trang</font></div><div style="padding-right:-15.4pt;text-align:justify"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">+ 41 589 112 110 (Geneva)</font></div><div style="padding-right:-15.4pt;text-align:justify"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">+ 1 817 615 2789 (Fort Worth)</font></div><div style="padding-right:-15.4pt;text-align:justify"><font style="color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%;text-decoration:underline">investor.relations&#64;alcon.com</font></div><div style="padding-right:-15.4pt;text-align:justify"><font><br></font></div></div><div style="display:inline-block;max-width:7.976%;min-width:6.976%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.013%"><div style="padding-right:-15.4pt;text-align:justify"><font style="color:#00aeef;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:700;line-height:115%;text-decoration:underline">Media Relations</font></div><div style="padding-right:-15.4pt;text-align:justify"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">Blake Overby</font></div><div style="padding-right:-15.4pt;text-align:justify"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">+ 41 589 112 111 (Geneva)</font></div><div style="padding-right:-15.4pt;text-align:justify"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">+ 1 817 551 8057 (Fort Worth)</font></div><div style="padding-right:-15.4pt;text-align:justify"><font style="color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%;text-decoration:underline">globalmedia.relations&#64;alcon.com</font></div></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:132%">4</font></div><div style="text-align:justify"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>alcon2q19pressrelease_imagb.gif
<TEXT>
begin 644 alcon2q19pressrelease_imagb.gif
M1TE&.#EA2 !( /(      $)GLDYQMUIZO'&-Q7V7RO___P   "'Y! $
M+     !( $@ 0@C_  $(#$"PH,&#"!,J7,BPH4  #2-*G$BQHL6)  QHW,BQ
M8\>+("-F],@QI$F0(TD:@'BRY4&5,&-N9.G294J2-&OJ1'C38\Z=0 /T[/@S
MJ-&C2!T.A9FTX@"9,IM27#I3:D6H6#T2L&J0@->O7ZEJ! "VK "N$L6N1'M2
M;5&V4V.^G0K7Z-RZ>(^6]7HV;T,!:E7ZY9F5Y&"#@0'T/<S0+>.T<A\7+$SY
M[E'*A>MBQFH9KF/)C2.#7OAY=,+2I@^B3EUPM<7..EU/A<T:<>W;N'/KEDQ
MH$S:< %C-AU8L&3AFPV +L[T<0&H O=ZE1RX@&[9J;$3%YU;.]Z'X!_*0@U/
M'FYRJ-;9GI>YF.MZF,!WOE<97^=\DENI<\?M??G^V_WI!]]N 3Y6(&,''I;@
58 OZU6!>#]IF580$@2=5A \%!  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>alcon2q19pressrelease_imagc.gif
<TEXT>
begin 644 alcon2q19pressrelease_imagc.gif
M1TE&.#EABP"  /0       !WM1" NB"(OC"1PT"9R%"BS&"JT7"SUH"[VI#$
MWZ#,X[#5Z,#=[=#F\>#N]O#W^____P
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EKDLC'-4DQCGZ$(5V--P;\Y@VA/$12@7[8Q8#)C!! C!? 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>logopressrelease2a01a.jpg
<TEXT>
begin 644 logopressrelease2a01a.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1V<17AI9@  34T *@    @ "  +  (
M   F   (>@$2  ,    !  $   $Q  (    F   (H $R  (    4   (Q@$[
M  (    1   (VH=I  0    !   ([)R=  $    B   1<.H<  <   @,
M;@  $9(<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                     %=I;F1O
M=W,@4&AO=&\@161I=&]R(#$P+C N,3 P,3$N,38S.#0 5VEN9&]W<R!0:&]T
M;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X-  R,#$Y.C X.C$W(#$R.C$Q.C0Q
M $-H96YG+"!#:')I<W1I;F$    &D ,  @   !0  !%&D 0  @   !0  !%:
MDI$  @    ,R,P  DI(  @    ,R,P  H $  P    $  0  ZAP !P  " P
M  DZ     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                        ,C Q
M.3HP.#HQ-R Q,3HU-CHP-P R,#$Y.C X.C$W(#$Q.C4V.C W    0P!H &4
M;@!G "P ( !# &@ <@!I ', = !I &X 80     & 0,  P    $ !@   1H
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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MC0 HHHHT ****- "BBBC0 HHHHT ****- "BBBC0 HHHHT ****- "BBBC0
MHHHHT ****- "BBBC0 HHHHT ****- "BBBC0 HHHHT ****- "BBBC0 HHH
MHT ****- "BBBC0 HHHHT ****- "BBBC0 HHHHT ****- "BBBC0 HHHHT
M****- "BBBC0 HHHHT ****- "BBBC0 HHHHT ****- "BBBC0 HHHHT ***
M*- "BBBC0 HHHHT ****- "BBBC0 HHHHT ****- "BBBC0 HHHHT ****0!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%=?H_P '/'_B#38-0TOP/XCU/3[A=T5W9:1<2Q.H;&X2*I4Y]C6-
M2M3HV]I*URHQE*]D<A16QXF\&^(/!=U';^(-"U30IYH_,BCU*SD@++D@MAU!
MP"/TK'K2,XSBI1=TQ--;A16MX;\):[XROFLM!T:_UN]5/,-OI]J\[A0<%L)G
MY<D<^];>J?!CX@Z%I]Q?ZEX%\2:?I]NGF375UI$\44:CJ6D90NWWS6<J]*$E
M&4DF_P!2E"4E=(XZBBBM^MB HHHI M0HHHIZ %%%%( HHHHT **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 5/9V,^H7D%K:QM/<3NL44:C)9V. GU
MS4%?3G_!/_X2'XB?&Z+6;J$OI/AJ,7TN?N-<$D0I[G<';_MF1TKDQN)6%P\J
MCZ&M*#J3Y4?HU\!?AC!\(/A/X>\+QK&);.V#7,B_QW#$M,?IO)'T '05\^?M
MC?LN_$?]H;QQI=SHE_H=MX?TNS,$$-]=2I(TKOF9R%C;LL8_X#]:^H_&_C#3
MOA[X.U?Q+J\K1Z;I=L]W,0>=J@_*/4G &/4BOF3_ (>:_#'_ * ?BCT_X]8/
M_CU?E6$6+J598BA'F9]145.,/93=D?1'PBTCQ!X?^&?AW2/%4MM+KVGVB6ES
M/9NSQRE/D5U9E4_,H!Y'>OBC_@IM\)?LNJ:!\0[.$B.Y3^S=0*]I%RT+'ZC<
MO_ 17T-\&/VV/ 7QN\;1>%]'MM6T[4IH99XO[2AC59=@#,JE9&^;:68#T0UZ
M)\=OAG#\7OA3XC\*RJGG7MLPMG8?<N%^:)OIO _,]JO#5:V7XV,ZJY>_S)J1
MCB*+A%GP!_P3/_Y+]J?_ & +C_T?!7W;^U5_R;C\0_\ L#S_ /H-?"W_  3=
MM)]-_:+URUN8FBN;?1+J*>%Q@QNMQ "OU#<5]S_M5-_QCC\0^/\ F#3_ /H-
M>GFKYLSBU_=.;"Q<<-*YY;_P3D\&6>A_L_Q:S'&OVS6[Z>:64_>VQNT,:^P
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M@X;UPLO\1Q9C?V@4445]:>4%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3CTS25K@\%2P5-PI=7<BK5E6=Y!1117<8A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/\C./UH'/M2"XE%%%,84444@>FX4444!N%%%% !1110 4444 %%%% !1110
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MQZ[I57^0J_;_  <\)VZX:PDE;UDNG_H:[?</4T<CJ"/R']:OEBMSD>:8R?\
MR\9S$/PS\*0-E=$MR?\ :W-_,U?B\%Z!"NU-%L0/>W4_TK9P<_=Q_GZ4X1O_
M '&/X'^F:7N+<QEBL7/_ )>2,^/1=.A^YI]HGT@3_"K:1I']Q%3_ '5 J:.U
MFF_U<;,/]D$_TK0@\+:Q<?ZG2KR;_KG S?T%2ZE-;M$>SQ53I+\3,5BOW3M^
MG%)]./IQ720_#?Q5<?ZOPWJI_P"W&4?S6KL/P?\ &=QT\.7Z_P"]"5_G7,\;
MAEO47WFWU/'2VIR_$X[)]3^='U.?KS7H$?P!\?R?=\.3?C)&/YM5V/\ 9O\
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M^M>T:;^RCXSO/FG;3[1?[KW#,W_CJ$5U>F?L=2R8>\\2QA?[EO:D_P#CQ?\
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M/3I\,Y53VHH\?M?V7_ =O_K;">?_ *Z7;C_T$BMNT^ /@.S^YX>A;_KH[O\
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M[3B<'??!7PM>?-'#<6C_ /3&X+?^A9KG[[]GNW;FQUB13_=FAW_^@XKUOG.
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M'\Z]>TK]GVXD"R:AJT:+_P \[1"__CYX_2NNTOX.>%]-^9[:6_D_OW4N/T7
MJN1G@U^(L#1^&7-Z'SK'%),P$:-)GH(U)/\ 6NDTOX;^)=8*^1H]PBM_%.OE
M@?\ ?16OI2PT>PTM0MG96]J!T\F)5/Y@5<ZC';T[5K[!GSU?BN7_ "Y@>%:7
M\ =5N"IOM1M;0?W(@96_/@5UNF_ G0+0;KJ:ZOS[R"-/T ->D9X ZCT/-+U.
M2"3ZGFJ4(GA5L\Q]7XI6]#!TWP'X=T?FUT:U1O[SQAV_-LFMP*%7: %7^Z.!
M^5.#9Z'</P_^M5NRT>^U2X$%G9SW,YZ111,[?D!G]*<FJ?QZ>IY<JM>OU<OO
M92X[  ^H&#2M\W#?,/0\BO0=%^ GCC7-K)HDMK$W\=T1#C_@+X;]*]!T3]C_
M %JZVG4M9L[,#JMNC3$_GLKS*V<8*A\51?+4].AD.88KX*+_ "/G[D=.*0$[
M@#C)Z+D U]>:+^R;X6LY%-_=7VH/W0RK&A_ #=^M>@Z/\%/!6@HHM?#MIQT,
MR^:?S<FO#K<48:"Y:2;9]/A^"<;55JDE%?UY'P;8Z1?ZI+LL[&XNI/\ GG%$
MQ/\ +^M=CH_P*\<ZU@P>'KJ)3WN@(?\ T+%?>5KI=I91B.WMHH(QT6- H_(5
M86-5& ,?2O%K<55Y_P ."7KJ?18?@+#K_>*KEZ:'QWI'[)/BF\8&^O;&Q0_W
M6:5A_P !"@?^/5VNE?L?:9$JMJ6OW5P>XM8EB'Z[Z^D,"@J&ZUY-7B#,*G_+
MRWH?28?A/*J'_+N_J>1:3^S+X&T_:S:?->.O1I[AR?R4@5V.F_#7POHN/L>@
MZ? P_B6W7=^>,UUFT>E&T>E>/4Q>(J?%49[M+*\%1_AT8KY%>."./A8E4>PI
M^P=ABI=HHVBN75[GHQ@H[$2J>A_E2LA_"I-HHQ1J5ML,VCTYH_"G[11M%&@P
MI:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** $Q3=OO3L4;10!'@^M'/IGZFI-HHQ2U[@1*"3R/TH:,-_"*E
MVC_)HVBGML*RZHIW%C;WD9CFB25#U61,C]:YK4_A-X0U@'[3X;L'+=66%4;\
MUP:['%&T>E:QJU(?!)KYG+4PM"M_$@GZI,\:U;]EOP/J*L8+>[TYFZM;W#?^
MU-U<3JO['MO(-VE^(9$7L+B /G_@2D#]*^FPH'08I/+7.<<_6O1HYMCJ.U5G
MC5^'<LQ'Q44O33\CXQU;]E/QAIX+6TECJ"=ECD*-_P"/8%<5J_P=\9:*Q^T^
M'K[;_>@02C_QS=7Z![!_DTGE)_=KV*/$V,I_&DSYVOP/@*G\&3A^)^:-U93V
M,ABN(9()%^\KIR/PR/YU7)_+_/N:_2G4-#T_5H3%>6<%U$>J31AU_(BN)UCX
M ^!=:R9= @A?LUJS08_!"*]FEQ5"7\6E;T/G<1P'77\&JGZH^#F^8Y.2?4TF
M2>3S]>:^LM6_9#T&Z5CINK7UDYZ+,%E4?A@']:X'6OV1_$UCN;3]0LM01?\
MGH6B8_\  2"/_'J]JCQ#@*WV[>J/F<1PKFV'^Q?T/"O?OZ]Z;<0I>1[)T6>/
M^Y*-R_D:[G6O@MXTT/=]H\/W;J/XK=1*/_'=U<?<V<]I,8IX9()5^\CJ01^!
M _G7LT\50K?PYIGS]3"XG#?%&4?O.3U+X:^&M6'[_1K=3_>@!C_]!(KE-4^
M6DW6Y[#4+JS]/,"RI^G->I<L,]O51D?SIN!Z9/K75[-=$:T<TQ>'_AS9X'JG
MP'U^SRUI<V=\GU,3?KFN2U3P3KVC,PN])NHU_OJN\?I7U3P.@Q3MQVD9./3M
M62IQ?PZGO4>)L7#^)%2/CDC;D' 8=0>/T.#0.?8^E?6>I^&-(UD'[;IMM<D]
M6>(;OSZUQVJ? _P[??/;"ZT]_6.8.GY-DUFZ;1[^'XHH5/=JKE/GRBO5-4^
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M(_\ OHX7_P >II7,*E:G15ZDK&12M\O4;?\ >&/ZUZMH7P#O;C:VJZA';?\
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ME&BE!X!X(/1LY%)2:L>@KM7044446%>^P4444AA1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>6APG^^3POXD5TSJ0HQYIM)'X-&G5Q4_<3E+MN8P^7IP?I3XH7FD"1QM(S'
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M5%Q<E+1'>45Y?XL^/.C>#]$\/ZI=V>I30:Y#Y]N((48QKM1OG^?C[Z_=W5S
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MA\WEL?+A!]E')_$U[/I>CV6BV:6UC:0V=O']R*$!5'T &*T5B55"J-J@8 '
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M.BF4@LX]\,/RJ7P#_P G6ZC_ -?U]_Z#)3OVC-+O?!WQ6TKQA;IO@D\B4/\
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MT/Y$9-CX;TS2])_LRTLHK:PV&/R(5V+M(P>GM7!_\,V_#MNN@D^QO+@]\_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
*HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
